Exascale Labs Holdings Inc. (NASDAQ: XLAB) Stock Competitors & Peer Comparison

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, MSFT has a market cap of 4T. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while MSFT trades at $539.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas MSFT's P/E ratio is 31.22. In terms of profitability, XLAB's ROE is N/A, compared to MSFT's ROE of +0.33%. Regarding short-term risk, XLAB is more volatile compared to MSFT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check MSFT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PLTR has a market cap of 461.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PLTR trades at $200.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PLTR's P/E ratio is 167.09. In terms of profitability, XLAB's ROE is N/A, compared to PLTR's ROE of +0.37%. Regarding short-term risk, XLAB is more volatile compared to PLTR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PLTR's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, ORCL has a market cap of 406.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while ORCL trades at $134.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas ORCL's P/E ratio is 17.62. In terms of profitability, XLAB's ROE is N/A, compared to ORCL's ROE of +0.43%. Regarding short-term risk, XLAB is more volatile compared to ORCL. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ORCL's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PANW has a market cap of 302.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PANW trades at $370.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PANW's P/E ratio is 98.48. In terms of profitability, XLAB's ROE is N/A, compared to PANW's ROE of +0.02%. Regarding short-term risk, XLAB is more volatile compared to PANW. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PANW's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CRWD has a market cap of 250.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CRWD trades at $244.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CRWD's P/E ratio is 238.02. In terms of profitability, XLAB's ROE is N/A, compared to CRWD's ROE of +0.01%. Regarding short-term risk, XLAB is more volatile compared to CRWD. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CRWD's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, FTNT has a market cap of 133.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while FTNT trades at $181.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas FTNT's P/E ratio is 60.44. In terms of profitability, XLAB's ROE is N/A, compared to FTNT's ROE of +1.88%. Regarding short-term risk, XLAB is more volatile compared to FTNT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FTNT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NET has a market cap of 112.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NET trades at $316.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NET's P/E ratio is 312.99. In terms of profitability, XLAB's ROE is N/A, compared to NET's ROE of -0.14%. Regarding short-term risk, XLAB is more volatile compared to NET. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NET's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, SNPS has a market cap of 91.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while SNPS trades at $468.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas SNPS's P/E ratio is 35.79. In terms of profitability, XLAB's ROE is N/A, compared to SNPS's ROE of +0.04%. Regarding short-term risk, XLAB is more volatile compared to SNPS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SNPS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while VMW trades at $142.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas VMW's P/E ratio is 42.92. In terms of profitability, XLAB's ROE is N/A, compared to VMW's ROE of +3.99%. Regarding short-term risk, XLAB is more volatile compared to VMW. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check VMW's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while SQ trades at $83.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas SQ's P/E ratio is 49.98. In terms of profitability, XLAB's ROE is N/A, compared to SQ's ROE of -0.04%. Regarding short-term risk, XLAB is more volatile compared to SQ. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SQ's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, XYZ has a market cap of 48B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while XYZ trades at $79.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas XYZ's P/E ratio is 26.09. In terms of profitability, XLAB's ROE is N/A, compared to XYZ's ROE of +0.02%. Regarding short-term risk, XLAB is more volatile compared to XYZ. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check XYZ's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, TWLO has a market cap of 42B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while TWLO trades at $273.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas TWLO's P/E ratio is 51.87. In terms of profitability, XLAB's ROE is N/A, compared to TWLO's ROE of +0.14%. Regarding short-term risk, XLAB is more volatile compared to TWLO. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TWLO's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CRWV has a market cap of 38.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CRWV trades at $69.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CRWV's P/E ratio is -34.53. In terms of profitability, XLAB's ROE is N/A, compared to CRWV's ROE of -0.45%. Regarding short-term risk, XLAB is more volatile compared to CRWV. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CRWV's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, ZS has a market cap of 35.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while ZS trades at $220.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas ZS's P/E ratio is 55.95. In terms of profitability, XLAB's ROE is N/A, compared to ZS's ROE of -0.03%. Regarding short-term risk, XLAB is more volatile compared to ZS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ZS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, OKTA has a market cap of 34.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while OKTA trades at $208.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas OKTA's P/E ratio is 58.90. In terms of profitability, XLAB's ROE is N/A, compared to OKTA's ROE of +0.04%. Regarding short-term risk, XLAB is more volatile compared to OKTA. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check OKTA's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, MDB has a market cap of 29.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while MDB trades at $366.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas MDB's P/E ratio is 69.28. In terms of profitability, XLAB's ROE is N/A, compared to MDB's ROE of +0.02%. Regarding short-term risk, XLAB is more volatile compared to MDB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check MDB's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NETE trades at $13.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NETE's P/E ratio is N/A. In terms of profitability, XLAB's ROE is N/A, compared to NETE's ROE of -1.70%. Regarding short-term risk, XLAB is more volatile compared to NETE. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NETE's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, VRSN has a market cap of 27.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while VRSN trades at $304.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas VRSN's P/E ratio is 33.60. In terms of profitability, XLAB's ROE is N/A, compared to VRSN's ROE of -0.39%. Regarding short-term risk, XLAB is more volatile compared to VRSN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check VRSN's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CPAY has a market cap of 26.7B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CPAY trades at $406.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CPAY's P/E ratio is 16.55. In terms of profitability, XLAB's ROE is N/A, compared to CPAY's ROE of +0.30%. Regarding short-term risk, XLAB is more volatile compared to CPAY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CPAY's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while SPLK trades at $156.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas SPLK's P/E ratio is 103.22. In terms of profitability, XLAB's ROE is N/A, compared to SPLK's ROE of +0.84%. Regarding short-term risk, XLAB is more volatile compared to SPLK. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SPLK's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, FFIV has a market cap of 25.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while FFIV trades at $456.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas FFIV's P/E ratio is 27.02. In terms of profitability, XLAB's ROE is N/A, compared to FFIV's ROE of +0.20%. Regarding short-term risk, XLAB is more volatile compared to FFIV. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FFIV's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, IOT has a market cap of 24.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while IOT trades at $42.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas IOT's P/E ratio is 68.66. In terms of profitability, XLAB's ROE is N/A, compared to IOT's ROE of +0.06%. Regarding short-term risk, XLAB is more volatile compared to IOT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check IOT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, RBRK has a market cap of 24.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while RBRK trades at $118.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas RBRK's P/E ratio is 439.22. In terms of profitability, XLAB's ROE is N/A, compared to RBRK's ROE of +0.50%. Regarding short-term risk, XLAB is more volatile compared to RBRK. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check RBRK's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while FLT trades at $303.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas FLT's P/E ratio is 22.97. In terms of profitability, XLAB's ROE is N/A, compared to FLT's ROE of +0.30%. Regarding short-term risk, XLAB is more volatile compared to FLT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FLT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CYBR has a market cap of 20.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CYBR trades at $408.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CYBR's P/E ratio is -139.06. In terms of profitability, XLAB's ROE is N/A, compared to CYBR's ROE of -0.07%. Regarding short-term risk, XLAB is more volatile compared to CYBR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CYBR's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NTNX has a market cap of 18.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NTNX trades at $69.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NTNX's P/E ratio is 38.65. In terms of profitability, XLAB's ROE is N/A, compared to NTNX's ROE of -3.96%. Regarding short-term risk, XLAB is more volatile compared to NTNX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NTNX's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, KSPI has a market cap of 18B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while KSPI trades at $94.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas KSPI's P/E ratio is 8.75. In terms of profitability, XLAB's ROE is N/A, compared to KSPI's ROE of +0.41%. Regarding short-term risk, XLAB is more volatile compared to KSPI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check KSPI's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, TOST has a market cap of 16.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while TOST trades at $32.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas TOST's P/E ratio is 29.02. In terms of profitability, XLAB's ROE is N/A, compared to TOST's ROE of +0.24%. Regarding short-term risk, XLAB is more volatile compared to TOST. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TOST's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GENVR has a market cap of 15.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GENVR trades at $1.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GENVR's P/E ratio is 0.45. In terms of profitability, XLAB's ROE is N/A, compared to GENVR's ROE of +0.42%. Regarding short-term risk, XLAB is more volatile compared to GENVR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GENVR's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GEN has a market cap of 14.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GEN trades at $24.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GEN's P/E ratio is 9.40. In terms of profitability, XLAB's ROE is N/A, compared to GEN's ROE of +0.42%. Regarding short-term risk, XLAB is more volatile compared to GEN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GEN's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NLOK trades at $21.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NLOK's P/E ratio is 15.15. In terms of profitability, XLAB's ROE is N/A, compared to NLOK's ROE of +0.42%. Regarding short-term risk, XLAB is more volatile compared to NLOK. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NLOK's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CHKP has a market cap of 14.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CHKP trades at $138.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CHKP's P/E ratio is 11.31. In terms of profitability, XLAB's ROE is N/A, compared to CHKP's ROE of +0.36%. Regarding short-term risk, XLAB is more volatile compared to CHKP. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CHKP's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GDDY has a market cap of 13.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GDDY trades at $107.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GDDY's P/E ratio is 15.92. In terms of profitability, XLAB's ROE is N/A, compared to GDDY's ROE of +6.61%. Regarding short-term risk, XLAB is more volatile compared to GDDY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GDDY's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, AKAM has a market cap of 13.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while AKAM trades at $92.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas AKAM's P/E ratio is 13.11. In terms of profitability, XLAB's ROE is N/A, compared to AKAM's ROE of +0.08%. Regarding short-term risk, XLAB is more volatile compared to AKAM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check AKAM's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, DOCN has a market cap of 12.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while DOCN trades at $109.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas DOCN's P/E ratio is 66.01. In terms of profitability, XLAB's ROE is N/A, compared to DOCN's ROE of +0.55%. Regarding short-term risk, XLAB is more volatile compared to DOCN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DOCN's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, SAIL has a market cap of 11.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while SAIL trades at $19.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas SAIL's P/E ratio is 70.54. In terms of profitability, XLAB's ROE is N/A, compared to SAIL's ROE of -0.03%. Regarding short-term risk, XLAB is more volatile compared to SAIL. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SAIL's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CFLT has a market cap of 11.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CFLT trades at $30.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CFLT's P/E ratio is -36.03. In terms of profitability, XLAB's ROE is N/A, compared to CFLT's ROE of -0.20%. Regarding short-term risk, XLAB is more volatile compared to CFLT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CFLT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PAYP has a market cap of 9.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PAYP trades at $14.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PAYP's P/E ratio is 11.85. In terms of profitability, XLAB's ROE is N/A, compared to PAYP's ROE of +0.36%. Regarding short-term risk, XLAB is more volatile compared to PAYP. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PAYP's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while ALTR trades at $111.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas ALTR's P/E ratio is 699.06. In terms of profitability, XLAB's ROE is N/A, compared to ALTR's ROE of +0.02%. Regarding short-term risk, XLAB is more volatile compared to ALTR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ALTR's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PLAN trades at $63.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PLAN's P/E ratio is -44.82. In terms of profitability, XLAB's ROE is N/A, compared to PLAN's ROE of -0.78%. Regarding short-term risk, XLAB is more volatile compared to PLAN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PLAN's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NTSK has a market cap of 8.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NTSK trades at $20.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NTSK's P/E ratio is -22.24. In terms of profitability, XLAB's ROE is N/A, compared to NTSK's ROE of -4.35%. Regarding short-term risk, XLAB is more volatile compared to NTSK. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NTSK's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, S has a market cap of 8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while S trades at $23.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas S's P/E ratio is 106.25. In terms of profitability, XLAB's ROE is N/A, compared to S's ROE of -0.23%. Regarding short-term risk, XLAB is more volatile compared to S. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check S's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, DBX has a market cap of 7.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while DBX trades at $36.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas DBX's P/E ratio is 12.64. In terms of profitability, XLAB's ROE is N/A, compared to DBX's ROE of -0.24%. Regarding short-term risk, XLAB is more volatile compared to DBX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DBX's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while INFA trades at $24.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas INFA's P/E ratio is 826.33. In terms of profitability, XLAB's ROE is N/A, compared to INFA's ROE of -0.00%. Regarding short-term risk, XLAB is more volatile compared to INFA. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check INFA's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PATH has a market cap of 7.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PATH trades at $13.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PATH's P/E ratio is 18.03. In terms of profitability, XLAB's ROE is N/A, compared to PATH's ROE of +0.18%. Regarding short-term risk, XLAB is more volatile compared to PATH. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PATH's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, HCP has a market cap of 7.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while HCP trades at $34.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas HCP's P/E ratio is -57.97. In terms of profitability, XLAB's ROE is N/A, compared to HCP's ROE of -0.16%. Regarding short-term risk, XLAB is more volatile compared to HCP. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check HCP's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while JCOM trades at $142.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas JCOM's P/E ratio is N/A. In terms of profitability, XLAB's ROE is N/A, compared to JCOM's ROE of +0.37%. Regarding short-term risk, XLAB is more volatile compared to JCOM. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check JCOM's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, QLYS has a market cap of 6.7B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while QLYS trades at $192.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas QLYS's P/E ratio is 25.15. In terms of profitability, XLAB's ROE is N/A, compared to QLYS's ROE of +0.37%. Regarding short-term risk, XLAB is more volatile compared to QLYS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check QLYS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, DOX has a market cap of 6.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while DOX trades at $60.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas DOX's P/E ratio is 8.36. In terms of profitability, XLAB's ROE is N/A, compared to DOX's ROE of +0.13%. Regarding short-term risk, XLAB is more volatile compared to DOX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DOX's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while SQSP trades at $46.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, XLAB's ROE is N/A, compared to SQSP's ROE of +0.03%. Regarding short-term risk, XLAB is more volatile compared to SQSP. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SQSP's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NEWR trades at $86.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NEWR's P/E ratio is -41.62. In terms of profitability, XLAB's ROE is N/A, compared to NEWR's ROE of -0.54%. Regarding short-term risk, XLAB is more volatile compared to NEWR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NEWR's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, WEX has a market cap of 6.2B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while WEX trades at $180.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas WEX's P/E ratio is 10.77. In terms of profitability, XLAB's ROE is N/A, compared to WEX's ROE of +0.28%. Regarding short-term risk, XLAB is more volatile compared to WEX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check WEX's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CCCS has a market cap of 5.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CCCS trades at $8.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CCCS's P/E ratio is -875.00. In terms of profitability, XLAB's ROE is N/A, compared to CCCS's ROE of +0.03%. Regarding short-term risk, XLAB is more volatile compared to CCCS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CCCS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, MBGL has a market cap of 5.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while MBGL trades at $18.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas MBGL's P/E ratio is 44.56. In terms of profitability, XLAB's ROE is N/A, compared to MBGL's ROE of +0.01%. Regarding short-term risk, XLAB is more volatile compared to MBGL. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check MBGL's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, VRNS has a market cap of 5.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while VRNS trades at $47.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas VRNS's P/E ratio is 205.83. In terms of profitability, XLAB's ROE is N/A, compared to VRNS's ROE of -0.27%. Regarding short-term risk, XLAB is more volatile compared to VRNS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check VRNS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, BOX has a market cap of 5.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while BOX trades at $39.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas BOX's P/E ratio is 26.32. In terms of profitability, XLAB's ROE is N/A, compared to BOX's ROE of +2.17%. Regarding short-term risk, XLAB is more volatile compared to BOX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check BOX's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, ACIW has a market cap of 5.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while ACIW trades at $52.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas ACIW's P/E ratio is 23.89. In terms of profitability, XLAB's ROE is N/A, compared to ACIW's ROE of +0.15%. Regarding short-term risk, XLAB is more volatile compared to ACIW. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ACIW's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, RELY has a market cap of 5.2B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while RELY trades at $24.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas RELY's P/E ratio is 17.73. In terms of profitability, XLAB's ROE is N/A, compared to RELY's ROE of +0.33%. Regarding short-term risk, XLAB is more volatile compared to RELY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check RELY's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, BB has a market cap of 5.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while BB trades at $8.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas BB's P/E ratio is 45.79. In terms of profitability, XLAB's ROE is N/A, compared to BB's ROE of +0.11%. Regarding short-term risk, XLAB is more volatile compared to BB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check BB's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CORZW has a market cap of 5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CORZW trades at $7.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CORZW's P/E ratio is -1.75. In terms of profitability, XLAB's ROE is N/A, compared to CORZW's ROE of +0.99%. Regarding short-term risk, XLAB is more volatile compared to CORZW. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CORZW's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NVEI trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NVEI's P/E ratio is 212.44. In terms of profitability, XLAB's ROE is N/A, compared to NVEI's ROE of -0.00%. Regarding short-term risk, XLAB is more volatile compared to NVEI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NVEI's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CORZ has a market cap of 4.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CORZ trades at $14.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CORZ's P/E ratio is -2.75. In terms of profitability, XLAB's ROE is N/A, compared to CORZ's ROE of +0.99%. Regarding short-term risk, XLAB is more volatile compared to CORZ. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CORZ's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, DLO has a market cap of 4.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while DLO trades at $15.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas DLO's P/E ratio is 20.41. In terms of profitability, XLAB's ROE is N/A, compared to DLO's ROE of +0.38%. Regarding short-term risk, XLAB is more volatile compared to DLO. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check DLO's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, TENB has a market cap of 4.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while TENB trades at $39.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas TENB's P/E ratio is 22.99. In terms of profitability, XLAB's ROE is N/A, compared to TENB's ROE of +0.02%. Regarding short-term risk, XLAB is more volatile compared to TENB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TENB's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CORZZ has a market cap of 4.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CORZZ trades at $13.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CORZZ's P/E ratio is -3.01. In terms of profitability, XLAB's ROE is N/A, compared to CORZZ's ROE of +0.99%. Regarding short-term risk, XLAB is more volatile compared to CORZZ. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CORZZ's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, FOUR has a market cap of 4.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while FOUR trades at $39.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas FOUR's P/E ratio is 7.34. In terms of profitability, XLAB's ROE is N/A, compared to FOUR's ROE of +0.06%. Regarding short-term risk, XLAB is more volatile compared to FOUR. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FOUR's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PAY has a market cap of 4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PAY trades at $32.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PAY's P/E ratio is 38.66. In terms of profitability, XLAB's ROE is N/A, compared to PAY's ROE of +0.15%. Regarding short-term risk, XLAB is more volatile compared to PAY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PAY's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while ESMT trades at $23.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas ESMT's P/E ratio is 153.67. In terms of profitability, XLAB's ROE is N/A, compared to ESMT's ROE of +0.03%. Regarding short-term risk, XLAB is more volatile compared to ESMT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ESMT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while SWI trades at $18.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas SWI's P/E ratio is 28.89. In terms of profitability, XLAB's ROE is N/A, compared to SWI's ROE of +0.08%. Regarding short-term risk, XLAB is more volatile compared to SWI. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SWI's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, AVPT has a market cap of 3.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while AVPT trades at $14.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas AVPT's P/E ratio is 41.31. In terms of profitability, XLAB's ROE is N/A, compared to AVPT's ROE of +0.16%. Regarding short-term risk, XLAB is more volatile compared to AVPT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check AVPT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, APPN has a market cap of 3.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while APPN trades at $43.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas APPN's P/E ratio is 50.37. In terms of profitability, XLAB's ROE is N/A, compared to APPN's ROE of +0.16%. Regarding short-term risk, XLAB is more volatile compared to APPN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check APPN's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while EVOP trades at $33.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas EVOP's P/E ratio is -309.00. In terms of profitability, XLAB's ROE is N/A, compared to EVOP's ROE of -0.03%. Regarding short-term risk, XLAB is more volatile compared to EVOP. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check EVOP's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, TDC has a market cap of 2.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while TDC trades at $31.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas TDC's P/E ratio is 10.32. In terms of profitability, XLAB's ROE is N/A, compared to TDC's ROE of +1.15%. Regarding short-term risk, XLAB is more volatile compared to TDC. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check TDC's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CLBT has a market cap of 2.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CLBT trades at $11.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CLBT's P/E ratio is 48.97. In terms of profitability, XLAB's ROE is N/A, compared to CLBT's ROE of +0.12%. Regarding short-term risk, XLAB is more volatile compared to CLBT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CLBT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NTCT has a market cap of 2.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NTCT trades at $38.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NTCT's P/E ratio is 14.57. In terms of profitability, XLAB's ROE is N/A, compared to NTCT's ROE of +0.07%. Regarding short-term risk, XLAB is more volatile compared to NTCT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NTCT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, STNE has a market cap of 2.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while STNE trades at $11.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas STNE's P/E ratio is 6.45. In terms of profitability, XLAB's ROE is N/A, compared to STNE's ROE of +0.30%. Regarding short-term risk, XLAB is more volatile compared to STNE. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check STNE's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, EEFT has a market cap of 2.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while EEFT trades at $65.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas EEFT's P/E ratio is 6.46. In terms of profitability, XLAB's ROE is N/A, compared to EEFT's ROE of +0.23%. Regarding short-term risk, XLAB is more volatile compared to EEFT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check EEFT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PAYO has a market cap of 2.4B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PAYO trades at $7.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PAYO's P/E ratio is 44.63. In terms of profitability, XLAB's ROE is N/A, compared to PAYO's ROE of +0.07%. Regarding short-term risk, XLAB is more volatile compared to PAYO. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PAYO's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, CSGS has a market cap of 2.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while CSGS trades at $80.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas CSGS's P/E ratio is 36.02. In terms of profitability, XLAB's ROE is N/A, compared to CSGS's ROE of +0.22%. Regarding short-term risk, XLAB is more volatile compared to CSGS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check CSGS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, RAMP has a market cap of 2.3B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while RAMP trades at $37.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas RAMP's P/E ratio is 15.14. In terms of profitability, XLAB's ROE is N/A, compared to RAMP's ROE of +0.16%. Regarding short-term risk, XLAB is more volatile compared to RAMP. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check RAMP's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GCT has a market cap of 2.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GCT trades at $59.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GCT's P/E ratio is 14.03. In terms of profitability, XLAB's ROE is N/A, compared to GCT's ROE of +0.31%. Regarding short-term risk, XLAB is more volatile compared to GCT. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GCT's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while AVDX trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas AVDX's P/E ratio is -250.00. In terms of profitability, XLAB's ROE is N/A, compared to AVDX's ROE of +0.01%. Regarding short-term risk, XLAB is more volatile compared to AVDX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check AVDX's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GETVV trades at $2.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GETVV's P/E ratio is N/A. In terms of profitability, XLAB's ROE is N/A, compared to GETVV's ROE of N/A. Regarding short-term risk, XLAB is more volatile compared to GETVV. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GETVV's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, FORG has a market cap of 2B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while FORG trades at $23.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas FORG's P/E ratio is -22.53. In terms of profitability, XLAB's ROE is N/A, compared to FORG's ROE of -0.20%. Regarding short-term risk, XLAB is more volatile compared to FORG. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check FORG's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GSKY trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GSKY's P/E ratio is 18.61. In terms of profitability, XLAB's ROE is N/A, compared to GSKY's ROE of +5.47%. Regarding short-term risk, XLAB is more volatile compared to GSKY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GSKY's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, ATEN has a market cap of 1.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while ATEN trades at $25.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas ATEN's P/E ratio is 25.91. In terms of profitability, XLAB's ROE is N/A, compared to ATEN's ROE of +0.20%. Regarding short-term risk, XLAB is more volatile compared to ATEN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ATEN's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, MQ has a market cap of 1.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while MQ trades at $18.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas MQ's P/E ratio is 195.37. In terms of profitability, XLAB's ROE is N/A, compared to MQ's ROE of +0.01%. Regarding short-term risk, XLAB is more volatile compared to MQ. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check MQ's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GET trades at $1.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GET's P/E ratio is 31.33. In terms of profitability, XLAB's ROE is N/A, compared to GET's ROE of N/A. Regarding short-term risk, XLAB is more volatile compared to GET. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GET's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PICS has a market cap of 1.7B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PICS trades at $13.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PICS's P/E ratio is 22.57. In terms of profitability, XLAB's ROE is N/A, compared to PICS's ROE of +0.28%. Regarding short-term risk, XLAB is more volatile compared to PICS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PICS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PGYWW has a market cap of 1.7B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PGYWW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PGYWW's P/E ratio is 0.01. In terms of profitability, XLAB's ROE is N/A, compared to PGYWW's ROE of +0.24%. Regarding short-term risk, XLAB is more volatile compared to PGYWW. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PGYWW's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NYAX has a market cap of 1.7B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NYAX trades at $44.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NYAX's P/E ratio is 212.27. In terms of profitability, XLAB's ROE is N/A, compared to NYAX's ROE of +0.04%. Regarding short-term risk, XLAB is more volatile compared to NYAX. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NYAX's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PRGS has a market cap of 1.7B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PRGS trades at $40.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PRGS's P/E ratio is 6.56. In terms of profitability, XLAB's ROE is N/A, compared to PRGS's ROE of +0.18%. Regarding short-term risk, XLAB is more volatile compared to PRGS. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PRGS's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while STER trades at $16.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas STER's P/E ratio is -98.47. In terms of profitability, XLAB's ROE is N/A, compared to STER's ROE of -0.00%. Regarding short-term risk, XLAB is more volatile compared to STER. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check STER's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, BAND has a market cap of 1.6B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while BAND trades at $49.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas BAND's P/E ratio is 33.74. In terms of profitability, XLAB's ROE is N/A, compared to BAND's ROE of +0.01%. Regarding short-term risk, XLAB is more volatile compared to BAND. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check BAND's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while ZUO trades at $10.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas ZUO's P/E ratio is -19.65. In terms of profitability, XLAB's ROE is N/A, compared to ZUO's ROE of -0.44%. Regarding short-term risk, XLAB is more volatile compared to ZUO. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check ZUO's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, PGY has a market cap of 1.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while PGY trades at $17.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas PGY's P/E ratio is 13.07. In terms of profitability, XLAB's ROE is N/A, compared to PGY's ROE of +0.24%. Regarding short-term risk, XLAB is more volatile compared to PGY. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check PGY's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while SUMO trades at $12.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas SUMO's P/E ratio is -11.36. In terms of profitability, XLAB's ROE is N/A, compared to SUMO's ROE of -0.31%. Regarding short-term risk, XLAB is more volatile compared to SUMO. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check SUMO's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, GB has a market cap of 1.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while GB trades at $7.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas GB's P/E ratio is 18.27. In terms of profitability, XLAB's ROE is N/A, compared to GB's ROE of +0.88%. Regarding short-term risk, XLAB is more volatile compared to GB. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check GB's competition here

Exascale Labs Holdings Inc. (NASDAQ: XLAB) plays a significant role within the Technology sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XLAB stands at 29M. In comparison, NN has a market cap of 1.5B. Regarding current trading prices, XLAB is priced at $1.36 on the NASDAQ, while NN trades at $10.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XLAB currently has a P/E ratio of 6.67, whereas NN's P/E ratio is -12.60. In terms of profitability, XLAB's ROE is N/A, compared to NN's ROE of -3.29%. Regarding short-term risk, XLAB is more volatile compared to NN. This indicates higher risk in terms of short-term price fluctuations for XLAB.Check NN's competition here